Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT)


Phase: III
Status: Not Recruiting

The COAPT Trial is studying the MitraClip device in heart failure patients with functional mitral regurgitation to whom the local heart team will not offer mitral valve surgery as a treatment option. The trial compares the MitraClip device with no device in patients currently receiving optimal medical therapy.

Principal Investigator

Chad Rammohan, MD


Evalve, Inc, a subsidiary of Abbott Vascular

NCT Number



Janet Lamm, Clinical Research Coordinator
Taft Center for Clinical Research

For more information about this clinical trial, including trial status, eligibility and full trial listing, visit